Grand Pacific Petrochemical Full Year 2024 Earnings: NT$1.42 loss per share (vs NT$1.59 loss in FY 2023)
Grand Pacific Petrochemical (TWSE:1312) Full Year 2024 Results
Key Financial Results
- Revenue: NT$16.4b (up 4.4% from FY 2023).
- Net loss: NT$1.56b (loss widened by 7.6% from FY 2023).
- NT$1.42 loss per share.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Grand Pacific Petrochemical's share price is broadly unchanged from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 1 warning sign for Grand Pacific Petrochemical you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TWSE:1312
Grand Pacific Petrochemical
Engages in the manufacture and sale of petrochemical and other chemical products in Taiwan.
Slightly overvalued with very low risk.
Similar Companies
Market Insights
Weekly Picks

The "Sleeping Giant" Stumbles, Then Wakes Up
Swiped Left by Wall Street: The BMBL Rebound Trade

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For
Recently Updated Narratives
The Real Power Behind Alphabet’s Growth
RELX: The Quiet Compounder Powering Law, Science, and Risk Intelligence
Why CVS’s Valuation Signals Opportunity
Popular Narratives

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

